Welcome to the Schizophrenia Resource Centre

Welcome, this website is intended for healthcare professionals in EMEA with an interest in the treatment of schizophrenia. By clicking the link below you are declaring and confirming that you are a healthcare professional

You are here

Prof. Peter Haddad - Editorial Board, Schizophrenia Resource Centre

Peter Haddad is a Consultant in Community Psychiatry in Salford and an Honorary Clinical Professor at the University of Manchester, UK.   His main clinical and research interests are the management of affective disorders and schizophrenia including the safety and side effects of psychiatric drugs.  He has published widely and is joint editor of two textbooks.  He was a member of the Guideline Development Group for the NICE 2006 Bipolar Guideline and the NICE 2009 Medicines Adherence Guideline.  He has contributed to other treatment guidelines including the British Association for Psychopharmacology Guidelines on the treatment of Schizophrenia and Bipolar Disorder.  He is an member of the editorial board of several international journals. 

 

In the last 3 years Peter Haddad has received fees for lecturing and/or consultancy (including attending advisory boards) from Bristol Myers Squibb, Eli Lilly, Janssen-Cilag, Lundbeck, Otsuka, Quantum Pharmaceutical, Sunovion, Takeda, Teva, Roche and Servier.  Several of these companies have provided support to attend conferences.

Stay informed

Subscribe to our E-Alert to keep up to date with the new items in the Resource Centre.

search this site

Search form

New levels of schizophrenia care through optimal delivery of treatment

Available to download for your personal use - Professor Emsley presents a selection of slides from ‘Empowering the Healthcare community: Reaching new levels in schizophrenia care’ as developed by the PsyAcademy Continuous Treatment Expert Committee.

 

View the video

Therapeutic actions of antipsychotics

Download lectures and guides on antipsychotics by Dr. Stephen M. Stahl:

View the video

Share